| Drug Name |
Tinidazole |
| Drug ID |
BADD_D02221 |
| Description |
A nitroimidazole antitrichomonal agent effective against _Trichomonas vaginalis_, _Entamoeba histolytica_, and _Giardia lamblia_ infections. |
| Indications and Usage |
For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients older than three years of age. |
| Marketing Status |
approved; investigational |
| ATC Code |
G01AF21; J01XD02; P01AB02 |
| DrugBank ID |
DB00911
|
| KEGG ID |
D01426
|
| MeSH ID |
D014011
|
| PubChem ID |
5479
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
51927-2391; 43386-550; 43386-551; 64980-426; 38779-2957; 42799-208; 0178-8500; 67296-1836; 14799-2005; 64980-427; 51552-0683; 42799-207; 0178-8250 |
| UNII |
033KF7V46H
|
| Synonyms |
Tinidazole | Tricolam | Fasigyn | Fasigyne | Fasigin | Fasygin | Simplotan | Bioshik | CP-12,574 | CP 12,574 | CP12,574 | CP-12574 | CP 12574 | CP12574 |
